Dr. David Perlmutter
speaker
551 appearances
1 recordings
1 series
first heard Jul 2026
last heard 9 Jul
Dr. David Perlmutter’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Jul 2026 with 1.
Appearances
If it were, then the drugs that are FD approved might be effective.
If it were.
Or or getting rid of the firemen 'cause they happen to be there.
You know, it's interesting.
About a month ago, a Cochrane analysis was published that looked at twenty thousand three hundred and forty-two individuals in seventeen studies, and the length of the studies were eighteen months looking at the drugs that are these monoclonal antibodies designed to reduce beta-amyloid in the brain as a treatment for Alzheimer's disease.
And the
I would say gold standard, a cochrane analysis said that these drugs, the their effectiveness is trivial.
And they are potentially very dangerous if not life threatening.
So when we look at risk benefit ratio, th this just doesn't add up.
There's no reason that we, I say we as a country, should be spending forty thousand dollars a year to treat people with these drugs because they do not work.
I can't tolerate statins, I've already tried.
So uh but I think we're talking a hypothetical here.
I I would not go near one of these beta amyloid drugs because you have a 25% risk of developing aria, amyloid-related imaging abnormalities, as if it's just an abnormality on the image, on the MRI scan.
No, it is an amyloid treatment-related brain hemorrhage or brain swelling.
So it's not amyloid-related, it's the treatment.
Treatment related.
These people don't have these hemorrhages until they start the drug.
Wow.
Call it like it is.
Uh and I actually I wrote a brief uh response to somebody uh in one of the uh trade journals.
Showing 141–160 of 551 · page 8 of 28
← Previous
Next →